{"title":"A pediatric case of resistant lichen planus pigmentosus treated with colchicine","authors":"Mehsas Zoubida, Sektaoui Soukaina, Boubnane Ibtissam, Znati Kaoutar, Senouci Karima, B. Laila","doi":"10.18203/issn.2455-4529.intjresdermatol20231164","DOIUrl":null,"url":null,"abstract":"This is a case report of a 8-year-old child with lichen planus pigmentosus (LPP), a rare subtype of pediatric lichen planus, successfully treated with colchicine after failure of other therapeutic options. Colchicine was introduced at a dose of 0.5mg/day for 1 year with sun protection, resulting in cessation of the eruption's extension and decrease in hyperpigmentation. No adverse effects were observed. This case highlights the potential of colchicine as a treatment option for pediatric patients with LPP, although further studies with larger sample sizes and longer follow-up periods are needed to establish its safety and effectiveness.","PeriodicalId":14331,"journal":{"name":"International Journal of Research in Dermatology","volume":"46 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Research in Dermatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18203/issn.2455-4529.intjresdermatol20231164","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
This is a case report of a 8-year-old child with lichen planus pigmentosus (LPP), a rare subtype of pediatric lichen planus, successfully treated with colchicine after failure of other therapeutic options. Colchicine was introduced at a dose of 0.5mg/day for 1 year with sun protection, resulting in cessation of the eruption's extension and decrease in hyperpigmentation. No adverse effects were observed. This case highlights the potential of colchicine as a treatment option for pediatric patients with LPP, although further studies with larger sample sizes and longer follow-up periods are needed to establish its safety and effectiveness.